These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2655687

  • 21. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
    Waeber B, Borges ET, Christeler P, Guillaume-Gentil M, Hollenstein U, Mannhart M.
    Cardiology; 1992; 80 Suppl 1():46-53. PubMed ID: 1534715
    [Abstract] [Full Text] [Related]

  • 22. Comparative trial of felodipine and nifedipine in refractory hypertension.
    Aberg H, Lindsjö M, Mörlin B.
    Drugs; 1985; 29 Suppl 2():117-23. PubMed ID: 3886357
    [Abstract] [Full Text] [Related]

  • 23. Experience with nitrendipine--a new calcium antagonist--in hypertension.
    Andrén L, Hansson L, Orö L, Ryman T.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S387-91. PubMed ID: 6184574
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the efficacy of nilvadipine and nitrendipine on circadian blood pressure.
    Keck M.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S43-9. PubMed ID: 1283188
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK, McMahon FG, Ryan JR, Maronde R, Vlachakis N, Mroczek W.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [Abstract] [Full Text] [Related]

  • 26. A placebo-controlled dose-response study of felodipine extended release in hypertensive patients.
    Liedholm H, Melander A.
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):109-13. PubMed ID: 2475701
    [Abstract] [Full Text] [Related]

  • 27. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
    Esper RJ, Esper RC, Baglivo HP, Castro JM, Rohwedder RW, Menna J.
    J Cardiovasc Pharmacol; 1984 Jul; 6 Suppl 7():S1096-9. PubMed ID: 6085374
    [Abstract] [Full Text] [Related]

  • 28. Altered pressor responses in long-term nitrendipine treatment.
    Simon G, Snyder DK.
    Clin Pharmacol Ther; 1984 Sep; 36(3):315-9. PubMed ID: 6380880
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of nitrendipine as baseline antihypertensive therapy.
    Rüddel H, Schmieder R, Langewitz W, Neus J, Wagner O, von Eiff AW.
    J Cardiovasc Pharmacol; 1984 Sep; 6 Suppl 7():S1049-52. PubMed ID: 6085365
    [Abstract] [Full Text] [Related]

  • 30. Muzolimine and nitrendipine in the treatment of arterial hypertension.
    de Divitiis O, Di Somma S, Petitto M, Galderisi M, Iacono C, Fazio S.
    Z Kardiol; 1985 Sep; 74 Suppl 2():60-5. PubMed ID: 3159163
    [Abstract] [Full Text] [Related]

  • 31. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A, Lasaridis A, Settas L.
    J Cardiovasc Pharmacol; 1984 Sep; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness of a new calcium antagonist in severe hypertension.
    Burris JF, Santangelo RP, Mroczek WJ.
    J Clin Pharmacol; 1986 Sep; 26(8):593-7. PubMed ID: 3793949
    [Abstract] [Full Text] [Related]

  • 33. Controlled trial of nifedipine and bendroflumethiazide in hypertension.
    Hallin L, Andrén L, Hansson L.
    J Cardiovasc Pharmacol; 1983 Sep; 5(6):1083-5. PubMed ID: 6196558
    [Abstract] [Full Text] [Related]

  • 34. Antihypertensive monotherapy with nitrendipine in general practice.
    Braun H, Weber F.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 1():S59-62. PubMed ID: 1723458
    [Abstract] [Full Text] [Related]

  • 35. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D, Burger KJ, Weidinger G.
    J Cardiovasc Pharmacol; 1990 Sep; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [Abstract] [Full Text] [Related]

  • 36. The acute and chronic effects of nitrendipine on plasma catecholamines in hypertensive patients.
    el-Beheiry H, Ruedy N, Wall RA, Murphy M, Wright JM.
    Can J Cardiol; 1993 Sep; 9(1):41-6. PubMed ID: 8439828
    [Abstract] [Full Text] [Related]

  • 37. Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension.
    Lopez LM, Mehta JL, Baz R, Aguila E.
    Clin Pharmacol Ther; 1984 Oct; 36(4):444-50. PubMed ID: 6478732
    [Abstract] [Full Text] [Related]

  • 38. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB, Bolli P, Erne P, Block LH, Kiowski W, Bühler FR.
    J Cardiovasc Pharmacol; 1984 Oct; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [Abstract] [Full Text] [Related]

  • 39. Once daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J, Robb OJ, Jeffers TA, Scott AK, Petrie JC, Towler HM.
    Br J Clin Pharmacol; 1987 Dec; 24(6):713-9. PubMed ID: 2964253
    [Abstract] [Full Text] [Related]

  • 40. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ, Meany TB, Johnston GD, Kondowe G, Grimmer SF, Breckenridge AM.
    J Cardiovasc Pharmacol; 1987 Dec; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.